Labelee - Allergen Scanner
By Ben Bagdady
Labelee is a privacy-focused allergen scanner for iOS that detects isothiazolinone compounds in product ingredient labels via on-device OCR.
The App DNA
What makes this app unique?
The app removes the cognitive and privacy friction of manually checking complex chemical names for users with contact dermatitis.
For Individuals with contact dermatitis or specific sensitivities to isothiazolinone-based allergens.
What does it look like?
Key features
Scans ingredient labels for 126+ compounds including MI, MCI, BIT, and OIT. Specialized database creates category authority for users with contact dermatitis, increasing retention through utility.
Processes ingredient labels locally using dual-pass processing for Latin and non-Latin scripts. Privacy-first mechanism removes the need for server-side data processing, reducing infrastructure costs.
Allows users to track specific sensitivities and save product safety status. Personalized tracking loop increases daily app utility, compounding user switching costs.
How much does it cost?
The app operates as a free, privacy-focused utility with no current monetization or account-gated tiers.
Velocity
Dormant developmentopaqueShow more...
Labelee has seen no development activity for 239 days. With only a single version released in the observed window, the app lacks a functional release cadence. There is no evidence of ongoing maintenance or feature updates, indicating a stagnant development status.
Who built it?
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Labelee - Allergen Scanner
How's the Health & Fitness market?
Labelee occupies a narrow niche in the Health & Fitness category, providing specialized allergen detection that generalist scanners often overlook. The lack of recent updates (240 days) creates a significant risk of churn as the app fails to keep pace with OS-level improvements.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Labelee - Allergen Scanner
Where is it heading?
The health-scanning market is consolidating around apps that offer frequent database updates and broader allergen coverage. Labelee's current trajectory is declining due to the lack of active development, which will likely lead to user attrition as competitors offer more robust, frequently updated alternatives.
- The 240-day update gap suggests the app is in maintenance mode, which erodes user confidence in a health-critical tool.
- The absence of monetization limits the resources available for database updates, which are essential for long-term category relevance.
The SWOT
- On-device OCR processing removes data-privacy friction for sensitive health information.
- Specialized database of 126+ isothiazolinone compounds creates immediate utility for a specific medical segment.
- Expansion into broader allergen categories could increase the addressable user base.
- Monetization via a premium tier for advanced health reports could sustain long-term development.
Next best moves
Ship stability update because the app has been dormant for 8 months → prevent platform-driven churn
The counter-intuitive read
The lack of monetization is a liability, not a strength: without revenue…
Read the full takeBottom line
Labelee provides immediate utility for a specific medical segment, but the 8-month development silence leaves the tool vulnerable to abandonment. The PM should prioritize a stability update to maintain the current user base before considering monetization experiments.
Unlock 2 critical frictions, 2 market threats and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated